These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7590652

  • 21. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E, Lalla T, Orphanou E, Sinakos E, Vrettou E, Raptopoulou-Gigi M.
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [Abstract] [Full Text] [Related]

  • 22. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN, Liaw YF, Atkins M.
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [Abstract] [Full Text] [Related]

  • 23. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C, Sevá-Pereira T, Alves-Filho G, Lorena SL, Soares EC, Mazzali M.
    Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 25. Chronic hepatitis B infection in Singapore.
    Yap I, Wee A, Guan R.
    Singapore Med J; 1991 Oct; 32(5):352-5. PubMed ID: 1793464
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B, Kalayci AG, Ozgenc F, Bosnak M, Davutoglu M, Ece A, Ozkan T, Ozeke T, Yagci RV, Haspolat K.
    Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW.
    Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF.
    Am J Med; 2004 Jun 15; 116(12):829-34. PubMed ID: 15178498
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar 15; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.